AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
4.380
-0.150 (-3.31%)
At close: Aug 28, 2025, 4:00 PM
4.600
+0.220 (5.02%)
After-hours: Aug 28, 2025, 7:44 PM EDT
AVITA Medical Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$14.75
Upside
+236.76%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Lake Street | Lake Street | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +82.65% | Aug 11, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 → $18 | Strong Buy | Maintains | $19 → $18 | +310.96% | Aug 8, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 | Strong Buy | Maintains | $19 | +333.79% | Jun 10, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $19 | Strong Buy | Maintains | $19 | +333.79% | Jun 6, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $22 | Strong Buy | Maintains | $22 | +402.28% | Apr 10, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $22 | Strong Buy | Maintains | $22 | +402.28% | Apr 4, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $22 | Strong Buy | Maintains | $22 | +402.28% | Mar 18, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 → $22 | Strong Buy | Maintains | $25 → $22 | +402.28% | Feb 20, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +470.78% | Feb 14, 2025 |
Lake Street | Lake Street | Strong Buy Maintains $20 → $14 | Strong Buy | Maintains | $20 → $14 | +219.63% | Jan 8, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +470.78% | Jan 8, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $21 | Buy | Reiterates | $21 | +379.45% | Dec 24, 2024 |
D. Boral Capital | D. Boral Capital | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +470.78% | Dec 24, 2024 |
Piper Sandler | Piper Sandler | Hold Reiterates $9 → $12 | Hold | Reiterates | $9 → $12 | +173.97% | Nov 8, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $21 | Buy | Reiterates | $21 | +379.45% | Aug 9, 2024 |
Piper Sandler | Piper Sandler | Buy → Hold Downgrades $21 → $9 | Buy → Hold | Downgrades | $21 → $9 | +105.48% | May 14, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.